SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Energy Fuels, Inc. is a mining development company, which engages in the exploration and evaluation of uranium and vanadium properties. It also operates the Nichols Ranch, Alta Mesa, and White Mesa Mill projects. The company was founded by George E. L. Glasier and John David Mason on June 24, 1987 and is headquartered in Lakewood, CO.

Energy Fuels Inc

Energy Fuels Inc. ($UUUU) is trending amid speculation around upcoming earnings and potential government contracts related to uranium and rare earth elements. Community discussions highlight the stock's volatility, with some traders pointing to unusual options activity and anticipating a significant price movement. Others suggest that any pullback represents a buying opportunity, citing the company's strategic importance in securing domestic supply chains.

Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. The company receives royalties for AZSTARYS from its commercial partner Corium. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.

Zevra Therapeutics Inc

ZVRA is trending as rumors of potential acquisition swirl, with the community buzzing about a potential buyout after reports of a failed financing attempt from a smaller company.  Enthusiasm is building for the upcoming earnings report and the potential for a positive outcome, while some investors express skepticism toward management. Bullish sentiment is further fueled by high short interest, leading to speculation about a possible short squeeze.

NLS Pharmaceutics Ltd. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutics for the treatment of neurobehavioral and neurocognitive disorders. Its product portfolio includes Quilience, a treatment for excessive daytime sleepiness and cataplexy associated with narcolepsy; and Nolazol, a treatment for attention deficit hyperactivity disorder. The company was founded by Ronald Hafner, Eric Konofal, and Alexander Zwyer on June 10, 2015 and is headquartered in Zurich, Switzerland.

NewcelX Ltd.

NCEL is trending as investors grapple with the implications of its recent merger and reverse stock split, with some expressing confusion and concern over trading discrepancies and stock valuations. Community discussions revolve around the potential for a short squeeze and the company's future prospects post-merger. The merger with Kadimastem is seen by some as a positive catalyst, while others remain skeptical about the combined entity's valuation and potential.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Denver, CO.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is trending as investors discuss its high valuation and potential ahead of earnings, with some pointing to strong AI growth and government contracts as reasons for optimism. The community is debating whether the stock can maintain its momentum and if it will beat expectations. Discussions include potential stock splits and comparisons to other high-growth tech companies.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals ($BCRX) is trending as investors anticipate upcoming earnings and key updates on its pipeline, including BCX17725 for Netherton syndrome. Community discussions focus on the potential for a positive conference call with improved guidance, overshadowing concerns about debt and valuation. Optimism surrounds the integration of Astria's assets and potential label expansion for Orladeyo, as analysts project earnings growth.

Space and Time is the Microsoft-backed blockchain for ZK-proven data. Powered by Proof of SQL, a sub-second ZK coprocessor, Space and Time allows smart contracts, AI agents, and onchain applications to query onchain and offchain data at scale and verify the results with cryptographic proofs. The foundation of Space and Time is a decentralized layer 1 blockchain where validators verify every piece of data that gets inserted into the network, updating and signing cryptographic commitments on the data before recording them onchain. Developers can query this data via Proof of SQL and receive back a trustless, tamperproof result onchain. Space and Time allows smart contracts to query over the full history of major blockchains and offchain sources in a verifiable way, enabling a new generation of sophisticated, data-driven onchain apps.  The SXT token is deployed as an ERC-20 token on Ethereum and functions as the network's native utility token. SXT is used for staking, data processing payments, access control, and incentives for data contributors.

Space and Time

Space and Time ($SXT) is trending amid community excitement surrounding its technology and partnerships, particularly with Microsoft and Chainlink. Discussions center on its potential for growth in the AI and decentralized data space, with some highlighting recent integrations and others anticipating a breakout. The community is closely watching for further developments that could drive broader adoption and price appreciation.

Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.

Gilead Sciences, Inc.

GILD is trending due to recent earnings and analyst upgrades, though the stock's reaction is mixed, with some questioning if investor expectations weren't fully met. Community discussions revolve around the company's HIV and oncology pipeline, potential acquisitions (such as RCUS or XLO), and the impact of regulatory decisions. Several actionable alerts and technical analyses are being shared, with call options being a popular strategy.

United States Commodity Funds LLC - United States Natural Gas Fund

United States Natural Gas Fund, LP

UNG is trending amid speculation around winter weather and potential supply constraints, with some traders anticipating a significant rally. Community discussions revolve around technical indicators, potential breakout levels, and the impact of data center energy consumption on natural gas demand. Despite strong storage levels, expectations of increased demand and potential disruptions are fueling bullish sentiment.

Direxion Shares ETF Trust - Direxion Daily Junior Gold Miners Index Bull 2X Shares

Direxion Daily Junior Gold Miners Index Bull 2X Shares

JNUG is trending due to LiquidTheta's LEAPS options alerts, sparking community interest in potential ROI. Additionally, news of China and Canada expanding trade and energy ties could provide tailwinds. However, concerns about consumer recession, layoffs, and banking stress are also circulating, adding complexity to the discussion around JNUG and junior gold miners.

Peloton Interactive, Inc. provides an at-home fitness platform for live and on-demand indoor cycling classes. The firm pioneered connected, technology-enabled fitness, and the streaming of immersive, instructor-led boutique classes for its members. It operates through the Connected Fitness Products and Subscription segments. The Connected Fitness Products segment includes the sales of bikes, tread & related accessories. The Subscription segment refers to the monthly subscription and credits from live studio classes. The company was founded by John Foley, Graham Stanton, Thomas Cortese, Yony Feng, and Hisao Kushi in 2012 and is headquartered in New York, NY.

Peloton Interactive Inc - Ordinary Shares - Class A

Peloton Interactive Inc

Peloton is trending as the community discusses its potential for a turnaround, fueled by recent analyst upgrades and speculation around new AI-integrated products. Community members are debating whether the stock is poised for a Carvana-like surge, while others caution about the impact of the broader economic environment and short interest.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

ShiftPixy, Inc. Announces Signed LOI to Acquire TurboScale

This press release is issued to update and clarify statements made in the previous release dated October 17, 2024. ShiftPixy, Inc. (Nasdaq: PIXY) (ShiftPixy or the Company), a Florida-based national...

FOLDShares of Amicus Therapeutics (FOLD) rose by 14% on Thursday after the company made a deal with Teva Pharmaceuticals to settle their patent dispute. Teva wanted to sell a generic version of Amicus' drug GALAFOLD before its patent expired.&nbsp;According to the agreement, Teva can start selling the generic version in the U.S. in 2037, if it gets approved by the FDA. Both companies have agreed to drop all legal cases related to this issue.BofA raised its price target for Amicus shares to $15 from $13 while maintaining its ‘Buy’ rating on the stock. BofA sees this as a positive step since other similar legal cases with Aurobindo and Lupin are still unresolved. The settlement also eases worries that investors had about the ongoing legal risks.<figure class="image"><a href="https://stocktwits.com/symbol/FOLD"><img style="aspect-ratio:641/141;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_10_17_232351_f081877e12.png" alt="Screenshot 2024-10-17 232351.png" width="641" height="141"></a><figcaption>Amicus Therapeutics Inc’s sentiment meter as of 1:50 p.m. ET on Oct. 17, 2024 | Source: Stocktwits</figcaption></figure>Retail sentiment on Stocktwits has flipped to ‘extremely bullish’ (97/100) from ‘extremely bearish’ just a day ago.&nbsp;PIXYShares of ShiftPixy Inc (PIXY) jumped 78% on Thursday after the national staffing enterprise&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/pixy-stock-jumps-after-acquisition-of-turboscale/cJ2bf0eRIJ">announced</a> the acquisition of TurboScale, an AI technology company specializing in scalable GPU cloud infrastructure and AI model deployment.&nbsp;<figure class="image"><a href="https://stocktwits.com/symbol/PIXY"><img style="aspect-ratio:643/139;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_10_17_232837_c9a1f738e9.png" alt="Screenshot 2024-10-17 232837.png" width="643" height="139"></a><figcaption>ShiftPixy Inc’s sentiment meter as of 1:55 p.m. ET on Oct. 17, 2024 | Source: Stocktwits</figcaption></figure>PIXY became the top trending ticker on Stocktwits on Thursday morning after the announcement. Retail sentiment around the stock is more ‘extremely bullish’ (95/100) from ‘bearish’ a day ago.&nbsp;BXBlackstone shares soared 7% on Thursday after the firm posted third-quarter earnings that surpassed Wall Street expectations.Wells Fargo has maintained its ‘Overweight’ rating on the stock and set a price target of $169. The brokerage noted that while Blackstone's Q3 earnings per share (EPS) were better than expected, the improvements were of "fairly low quality," mainly due to favorable changes in the tax rate and other less reliable factors.&nbsp;<figure class="image"><a href="https://stocktwits.com/symbol/BX"><img style="aspect-ratio:643/141;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_10_17_233818_5961473307.png" alt="Screenshot 2024-10-17 233818.png" width="643" height="141"></a><figcaption>Blackstone Inc’s sentiment meter as of 1:50 p.m. ET on Oct. 17, 2024 | Source: Stocktwits</figcaption></figure>Retail sentiment on Stocktwits has shifted to ‘extremely bullish’ (94/100) from ‘bearish’ a day ago.&nbsp;For updates and corrections email newsroom@stocktwits.com.Read more:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/tsmc-stock-surges-pre-market-on-quarterly-profit-jump/cJ2bJ8gRIE">TSMC Stock Surges Pre-Market, Lifting Apple and Nvidia After Quarterly Profit Jump – Retail Rejoices</a>

Amicus Therapeutics, ShiftPixy, and Blackstone experience significant stock surges as retail sentiment turns extremely bullish after key developments.

Amicus Therapeutics, ShiftPixt, Blackstone: Retail Investors Turn Most Bullish On These 3 Stocks

Amicus Therapeutics soared after resolving a patent dispute, while ShiftPixy jumped on its AI acquisition. Blackstone gained following a strong earnings report.

Equity

Shares of Florida-based national staffing enterprise ShiftPixy Inc (PIXY) jumped 150% on Thursday after the firm <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.businesswire.com/news/home/20241017922928/en/ShiftPixy-Inc.-Announces-Acquisition-of-TurboScale">announced</a> the acquisition of TurboScale, an AI technology company specializing in scalable GPU cloud infrastructure and AI model deployment.PIXY became the top trending ticker on Stocktwits on Thursday morning after the announcement. The deal size amounts to $150 million, which was structured with $75 million in stock and $75 million in debt.TurboScale CEO Chandler Song said ShiftPixy provides a perfect platform for many use cases of AI to blossom. “The two companies plan to build training and inference infrastructure for vertical AIs that include HR, Sales, Customer Services, and many more,” he said.ShiftPixy said that the acquisition will allow the firm to introduce enhanced AI-powered features, such as real-time predictive analytics and machine learning-driven automation, to streamline workforce management.“By integrating TurboScale’s advanced GPU cloud and AI technology, ShiftPixy will enhance its ability to optimize staffing efficiency, improve labor forecasting, and offer advanced AI-driven workforce solutions for clients across multiple industries,” the firm said.According to ShiftPixy, TurboScale’s platform offers cost-efficient, highly configurable virtual machines and private cloud solutions, tailored to meet the diverse needs of enterprises, from small experiments to large-scale AI deployments.Following the announcement, retail sentiment on Stocktwits jumped into the ‘extremely bullish’ territory (94/100), accompanied by 'extremely high' message volumes.<figure class="image"><a href="https://stocktwits.com/symbol/PIXY"><img style="aspect-ratio:1648/466;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_10_17_at_9_36_19_AM_915334dd1c.png" alt="PIXY sentiment meter as of 9:36 a.m. ET on Oct. 17, 2024 | Source: Stocktwits" width="1648" height="466"></a><figcaption>PIXY sentiment meter as of 9:36 a.m. ET on Oct. 17, 2024 | Source: Stocktwits</figcaption></figure>Shares of PIXY have recorded losses of over 83% on a year-to-date basis.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/blackstone-q3-tops-estimates/cJ2b90ARII">Blackstone Beats Q3 Estimates, AUM Reaches Record $1.11T: Stock Rises, But Retail Caution Lingers</a>For updates and corrections email newsroom@stocktwits.com

PIXY became the top trending ticker on Stocktwits on Thursday morning after the deal announcement | Representative Image Source: Pexels

PIXY Stock Jumps After Acquisition Of TurboScale: Retail Turns Extremely Bullish

The deal size amounts to $150 million, which was structured with $75 million in stock and $75 million in debt.

ShiftPixy's Big AI Move: Supercharges Workforce Management With $150M TurboScale Deal

ShiftPixy stock surged after announcing its $150 million acquisition of TurboScale, enhancing its AI capabilities.PIXY
read more...

ShiftPixy, Inc. Announces Acquisition of TurboScale

ShiftPixy, Inc. (Nasdaq: PIXY) (ShiftPixy or the Company), a Florida-based national staffing enterprise which designs, manages, and sells access to a disruptive, revolutionary platform that...

How Is The Market Feeling About ShiftPixy?

AAR, ShiftPixy And 3 Stocks To Watch Heading Into Monday

ShiftPixy, Inc. Announces Reverse Stock Split Effective Date

ShiftPixy Announces Pricing of $2.5 Million Offering

ShiftPixy, Inc. (Nasdaq: PIXY) ('ShiftPixy' or the 'Company'), a Florida-based national staffing enterprise which designs, manages, and sells access to a disruptive, revolutionary platform that...

Global Human Capital Management (HCM) Market Expected to Reach $63.14 Billion By 2032

PALM BEACH, Fla., April 02, 2024 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - Human Capital management market has been steadily growing over the past years and is expected to continue...

ShiftPixy, Inc. engages in the provision of human capital services. Its services include employment tax processing, human resources and employment compliance, employment related insurance, and employment administrative services solutions. The company was founded by Scott W. Absher and J. Stephen Holmes on June 3, 2015 and is headquartered in Miami, FL.

ShiftPixy Inc

Will Palantir ($PLTR) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

) beat quarterly earnings? 
 
*Powered by Polymarket

Current Price	$6.53
Prev Close	$7.62
Open	$7.59
Dividend Yield	N/A
50-Day Moving Average	$6.53
Beta	0.95
Avg. Volume	0.00
PE Ratio	N/A

52-Week High	$6.53
52-Week Low	$6.53
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A
Enterprise Value/EBITDA	N/A

PIXY
ShiftPixy Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest PIXY News

PIXYShiftPixy Inc